If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
83.70    -1.10 (-1.30%)
Bid:
83.60
Ask:
84.30
Spread: 0.70 (0.837%)
Market Cap: £237.26m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Director/PDMR Shareholding - Replacement

1 Apr 2021 16:17

RNS Number : 3828U
Essentra plc
01 April 2021
 

Essentra plc Director/PDMR Shareholding

Notification and public disclosure of transactions by persons discharging managerial responsibility

 

A non material typographical change has been made to the ‘Essentra plc Director/PDMR' announcement released on 1 April 2021 at under RNS No 3811U.

 The changes are identified with an asterisk (*).

 The full amended text is shown below.

 

The notification below, is made on behalf of Richard Cammish, a Person Discharging Managerial Responsibility (PDMR) in Essentra plc, under article 19.1 of the Market Abuse Regulation ('MAR') and in accordance with Article 19.3 of MAR.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Richard Cammish

2

 

Reason for the notification

a)

 

Position/status

Chief Information Officer

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Essentra plc

b)

 

LEI

5493007MOZNA03BVNE96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 25p shares

 

 

Identification code

GB00B0744359

 

 

b)

 

Nature of the transaction

 

 

Sale of shares

c)

 

Price(s) and volume(s)

Price (£)

Volume

2.973012

25,229

 

 

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

 

 

- Aggregated volume

25,229

 

 

 

 

- Price

£75,006

 

 

 

 

e)

 

Date of the transaction

 

3 March 2021

 

f)

 

Place of the transaction

London Stock Exchange (XLON)

 

     

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

 

Name

Richard Cammish

 

2

 

Reason for the notification

 

 

a)

 

Position/status

Chief Information Officer

 

b)

 

Initial notification /Amendment

 

Initial

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

Essentra plc

 

b)

 

LEI

5493007MOZNA03BVNE96

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 25p shares

 

 

 

 

Identification code

GB00B0744359

 

 

 

 

b)

 

Nature of the transaction

 

Exercise and sale of shares awarded under the Long Term Incentive Plan Part B

 

c)

 

Price(s) and volume(s)

Price (£)

Volume

2.914248

10,997

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

10,997

 

 

- Price

£32,048

 

 

e)

 

Date of the transaction

 

1 April 2021*

f)

 

Place of the transaction

London Stock Exchange (XLON)

     

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Richard Cammish

2

 

Reason for the notification

 

a)

 

Position/status

Chief Information Officer

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

Essentra plc

b)

 

LEI

5493007MOZNA03BVNE96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 25p shares

 

 

Identification code

GB00B0744359

 

 

b)

 

Nature of the transaction

 

Sale of shares awarded under Employee Share Plan

c)

 

Price(s) and volume(s)

Price (£)

Volume

2.925475

3,095

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

3,095

 

 

- Price

£9,054

 

 

e)

 

Date of the transaction

 

1 April 2021*

f)

 

Place of the transaction

London Stock Exchange (XLON)

     

 

Enquiries

 

Emma Reid - Head of Governance

T: 01908 359100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKDBKPBKDFQK
Date   Source Headline
2nd Sep 202111:36 amRNSTotal Voting Rights
13th Aug 20217:00 amRNSAppointment of Board Trainee
3rd Aug 20217:00 amRNSCompletion of Components Acquisition in China
2nd Aug 20217:00 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSResults for the Half Year Ended 30 June 2021
20th Jul 202112:00 pmRNSInvitation to HY 2021 Results Presentation
7th Jul 20217:00 amRNSHY 2021 Pre-Close Trading Update
1st Jul 20217:50 amRNSChange of Registered Office
1st Jul 20217:48 amRNSTotal Voting Rights
28th Jun 20214:02 pmRNSDirectorate Change
25th Jun 20215:01 pmRNSAppointment of a Non-Executive Director
2nd Jun 20218:25 amRNSTotal Voting Rights
28th May 20213:38 pmRNSHolding(s) in Company
20th May 202112:30 pmRNSResult of AGM
20th May 20217:00 amRNSAGM 2021 Trading Update
18th May 20217:25 amRNSDirector Declaration
13th May 20217:00 amRNSComponents Acquisition in China
4th May 202111:21 amRNSTotal Voting Rights
21st Apr 20217:00 amRNSHolding(s) in Company
16th Apr 20217:00 amRNS1st Quarter Results
9th Apr 202111:00 amRNSForthcoming Q1 2021 Trading Update
1st Apr 20214:17 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20213:59 pmRNSDirector/PDMR Shareholding
1st Apr 20213:56 pmRNSDirector/PDMR Shareholding
1st Apr 20213:54 pmRNSDirector/PDMR Shareholding
1st Apr 202110:10 amRNSTotal Voting Rights
30th Mar 20212:53 pmRNSDirector/PDMR Shareholding
30th Mar 202112:24 pmRNSDirector/PDMR Shareholding
10th Mar 20213:52 pmRNSDirector/PDMR Shareholding
5th Mar 20217:05 amRNSBoard Changes
5th Mar 20217:00 amRNSResults for the Full Year Ended 31 December 2020
2nd Mar 202111:41 amRNSHolding(s) in Company
1st Mar 20218:30 amRNSTotal Voting Rights
26th Feb 202112:00 pmRNSInvitation to Full Year 2020 Results Presentation
24th Feb 20214:03 pmRNSHolding(s) in Company
2nd Feb 20211:00 pmRNSDate for FY 2020 Results Announcement
1st Feb 20218:53 amRNSTotal Voting Rights
27th Jan 20217:12 amRNSDirector Declaration
8th Jan 20217:00 amRNSFY20 Pre-Close Trading Statement
4th Jan 20217:00 amRNSTotal Voting Rights
24th Dec 20207:00 amRNSHolding(s) in Company
4th Dec 202011:58 amRNSDirector Declaration
1st Dec 20208:11 amRNSTotal Voting Rights
27th Nov 20204:40 pmRNSSecond Price Monitoring Extn
27th Nov 20204:35 pmRNSPrice Monitoring Extension
16th Nov 202011:42 amRNSHolding(s) in Company
2nd Nov 202011:08 amRNSTotal Voting Rights
29th Oct 20204:41 pmRNSDirector/PDMR Shareholding
29th Oct 20204:37 pmRNSDirector/PDMR Shareholding
23rd Oct 20207:00 amRNSQ3 2020 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.